Systematic review identifies biomarkers predicting major adverse cardiovascular events in chronic kidney disease, suggesting future research directions.
Key Points
The review finds several biomarkers predictive of major adverse cardiovascular events in end-stage kidney disease patients, impacting clinical decisions.
Among 14 studies with 4965 participants, results indicated that traditional and novel biomarkers are significant in predicting cardiovascular risks.
The systematic review utilized standard Cochrane methods and includes findings from both haemodialysis and peritoneal dialysis patients.
Further large-scale research is necessary to validate biomarker efficacy for cardiovascular risk in patients with chronic and end-stage kidney disease.